Next generation intra-and transdermal therapeutic systems: using non-and minimally-invasive technologies to increase drug delivery into and across the skin
T Gratieri, I Alberti, M Lapteva, YN Kalia - European Journal of …, 2013 - Elsevier
The number of drug molecules approved by the regulatory authorities for transdermal
administration is relatively modest–less than two dozen. Many other therapies might benefit …
administration is relatively modest–less than two dozen. Many other therapies might benefit …
[引用][C] Next generation intra-and transdermal therapeutic systems: Using non-and minimally-invasive technologies to increase drug delivery into and across the skin
T Gratieri, I Alberti, M Lapteva, YN Kalia - European Journal of …, 2013 - cir.nii.ac.jp
Next generation intra- and transdermal therapeutic systems: Using non- and minimally-invasive
technologies to increase drug delivery into and across the skin | CiNii Research CiNii 国立 …
technologies to increase drug delivery into and across the skin | CiNii Research CiNii 国立 …
Next generation intra-and transdermal therapeutic systems: using non-and minimally-invasive technologies to increase drug delivery into and across the skin
T Gratieri, I Alberti, M Lapteva… - European journal of …, 2013 - pubmed.ncbi.nlm.nih.gov
The number of drug molecules approved by the regulatory authorities for transdermal
administration is relatively modest-less than two dozen. Many other therapies might benefit …
administration is relatively modest-less than two dozen. Many other therapies might benefit …
Next generation intra-and transdermal therapeutic systems: using non-and minimally-invasive technologies to increase drug delivery into and across the skin.
T Gratieri, I Alberti, M Lapteva… - European Journal of …, 2013 - europepmc.org
The number of drug molecules approved by the regulatory authorities for transdermal
administration is relatively modest-less than two dozen. Many other therapies might benefit …
administration is relatively modest-less than two dozen. Many other therapies might benefit …
Next generation intra-and transdermal therapeutic systems: Using non-and minimally-invasive technologies to increase drug delivery into and across the skin
T Gratieri, I Alberti, M Lapteva, YN Kalia - European Journal of …, 2013 - infona.pl
The number of drug molecules approved by the regulatory authorities for transdermal
administration is relatively modest–less than two dozen. Many other therapies might benefit …
administration is relatively modest–less than two dozen. Many other therapies might benefit …